(2R,3R)-Me-BIDIME is primarily utilized in the field of asymmetric synthesis, where it serves as a chiral ligand. Its application is particularly significant in catalytic processes, such as enantioselective hydrogenation and carbon-carbon bond formation reactions. The compound's chiral structure enables the production of optically active molecules, which are crucial in the pharmaceutical industry for the synthesis of drugs with specific stereochemical requirements. Additionally, it is employed in academic research to explore new methodologies in organic synthesis, contributing to the development of more efficient and selective catalytic systems.